1. Chances of having a mental illness in your lifetime in Canada: One in five.
  2. Depression is the Fourth leading cause of disability and premature death in the world.
  3. 2020 is predicted that depression will become the second leading cause of disability in the world (next to heart disease).
  4. At any given time, percentage of Canadians who have a mental illness: 10.4%
  5. Percentage of adolescents (aged 15 – 24) who report a mental illness or substance abuse problem: 18%.
  6. Percentage of people who commit suicide who have a diagnosable mental illness: 90%.
  7. Percentage of Canadians who will experience a major depression in their lifetime: 8%.
  8. Number of suicides in Canada every year: Approximately 4000.
  9. Canadians are the Highest per capita users of psychiatric medications in the world.
  10. Without antidepressants: About 20 to 40 out of 100 people who took a placebo noticed an improvement of their symptoms within six to eight weeks.
(Source : The Mood Disorders Society of Canada October, 2009)

Depression is a treatable — Get Help now!

Our Approach
depression happy coupleAt Neurotherapy Montreal, we see patients with many types of depression :mild,moderate,severe,some chronic and debilitating,some caused by a traumatic event or a medical condition. Unfortunately, depression treatments don't always work.

• As many as two-thirds of people with depression aren't helped by the first antidepressant they try.

Up to a third don't respond to several attempts at treatment.

Treatment-resistant depression (TRD) solutions leave you feeling hopeless and discouraged.

Symptoms are wide-ranging and typically include:
  • Depressed mood
  • Feelings of guilt, worthlessness, helplessness or hopelessness
  • Loss of interest or pleasure in usually-enjoyed activities
  • Change in weight or appetite
  • Sleep disturbances
  • Decreased energy or fatigue (without significant physical exertion)
  • Thoughts of death
  • Poor concentration of difficulty making decisions

What about Long-term Depression Effects on your body?

When you are exposed to a depressive state for long period of time you can develop serious health issues

Take a look to the following graphic!depression long term

Knowing your particular type of Depression is the condition for selecting the good treatment.

“ One Size cannot Not Fit All! ”

The Diagnostic at Neurotherapy Montreal uses 4 Factors

Evaluate chemistry, function and brain activity to understand your depression!

Your Biologic State
General Medical Evaluation
  • If you do not have a recent medical check up, we will order lab tests to rule out kidneys, liver or thyroid malfunction, hormone imbalances, toxicity, etc.
    — if deemed necessary
  • Heart Rate Variability (HRV) — This test measures your heart rate and breathing patterns

Genetics and biology play a role in the creation of depression disorders. 

Your Psychological Status
Psychological assessments
- Will include some combination of
  • Cognitive ability tests used to assess processing of information
  • Behaviour check-lists
  • Some assessments will include projective tests, which are used to help understand underlying emotional concerns and beliefs
  • Some assessments will include tests related to mental health in combinations with clinical interviews
Your Brain Activity
Recording your Brain Activity (qEEg)
We will record two brain mappings:
  • We will record two brain mappings: one at rest and one during concentration to identify region of the brain that do not work well
  • We will test Frontal alpha asymmetry (the relative difference in power between two signals in different hemispheres) has been suggested as bio-marker for depression.

qEEG technology is at the core of our assessment

depression qeegqEEg Recording Sample
Neurological patterns found associated with depression are asymmetry of frontal lobe activity, deficiency of slow-wave (theta) activity or excessive fast wave (beta) activity in the occipital or posterior region of the brain, as well as deficiency in 13-15 Hz activity over the sensorimotor cortex.

Most traditional Depression treatments overlook the cause

Psychotherapy and medication are common ways to treat depression.This can be helpful to manage in the short term, The underlying cause remains, so you’re never really free of depression.

How do we treat Depression?
Neurotherapy Montreal combines classic Psychotherapy with Repetitive transcranial Magnetic Stimulation (rTMS), Neurofeedback and HRV (Heart Rate Variability) training to restore network-connectivity in the brain.

Transcranial Magnetic Stimulation (rTMS)

Brain Stimulation is a proven treatment for depression when medications and therapy have failed or not tolerated

depression rtmsrTMS is a procedure in which cerebral electrical activity is influenced by a pulsed magnetic field. The magnetic field is generated by passing brief current pulses through a figure 8 coil. This coil is encased in plastic and is held close to the scalp so that the magnetic field can be focused onto specific areas of the cortex, or surface, of the brain — It is a safe and efficient procedure

rTMS therapy is approved by Health Canada & the FDA (USA) and by the RAMQ

Our approach is safe, efficient with lasting effects

Our evidence-based approach is unique because we focus on your Bio-psycho and neurosignature.

- Non-invasive neuromodulation and Cognitive neuroscience have evolved into powerful tools for Patients who suffer from depression.

Learn More…
If You have any Questions or want to Scheduled a Visit.

  Contact Us

See How the Montreal Neurotherapy Center Can Help!

Or by Phone —

(514) 481-7867

Click the following Tabs to consult

Depression General Information

About Depression & rTMS therapy

Depression & rTMS therapy

In treating depression, rTMS therapy targets the area in the left cerebral hemisphere just a few inches above the temple and beneath the skull. This area is called the left dorsolateral prefrontal cortex (L-DLPFC). The L-DLPFC is readily accessible to the magnetic field and is highly interconnected with limbic structures, which play a dominant role in mood modulation and major depression.

rTMS is used to treat depression by inducing a current in the L-DLPFC with stimulation by a magnetic field. The stimulations are short but intense, lasting less than a millisecond. The penetration itself holds little energy. Several studies have suggested that rTMS regulates beta adreno-receptors and increases dopamine and serotonin levels.

Some remote brain structures are also believed to be linked to depression.
rTMS may alter activity in these structures not directly accessible to the rTMS coil by focal cortical stimulation. The indirect stimulation occurs via trans-synaptic effects. This means that the accessible areas of the brain, such as the L-DLPFC described above, are first directly stimulated by the magnetic field. This direct stimulation may in turn cause the inaccessible areas of the brain to be stimulated.

The human brain is a natural electrical organ that functions by transmitting electrical signals from one nerve cell to another. Brain imaging techniques demonstrate that individuals suffering from depression often display insufficient levels of glucose metabolism, lower blood flow in the L-DLPFC and increased activity in the limbic system.
rTMS acts on this process by regulating the flow of interactions between neurons that will appropriately increase or decrease the desired regions to relieve the depression.
Acute treatment for depression consists of 20-30 rTMS sessions, over 4-6 consecutive weeks (excluding weekends)


Depression Videos

Transcranial Magnetic Stimulation
Transcranial Magnetic Stimulation
Electromagnetic Therapy Offers Hope for Depression
Electromagnetic Therapy Offers Hope for Depression
Previous Next Play Pause


Depression Literature & Research

Research Publications About TMS In Depression We participate

Research Publications About TMS In Depression We participate

(Link — http://tmslosangeles.com/Articles.html#Leuchter2013

The latest: ABC7 News covers a new study at UCLA, already showing promising results, that uses TMS to see if administering mild electrical currents into the brain can reset its networks for those dealing with post-traumatic stress disorder.

•  See more on this video

Contemporary perspectives on neuromodulation are summed up in a recent review from our group (Cook, et al., 2014), which also discusses some of the innovations in neuromodulation from UCLA (e.g., sTMS and TNS). As well, we have proposed a new theoretical framework for understanding the mechanisms of action for various forms of magnetic stimulation (Leuchter, et al., 2013)

Many research studies over the past two decades have examined the use of transcranial magnetic stimulation in the management of depression. The early TMS studies contributed important information about aspects of effective dose, stimulation parameters, safety, and tolerability. The meta-analytic review paper by Gross and colleagues (2007) helps summarize much of this work, as does the report from Slotema and colleagues (2010).

• The papers by O'Reardon, et al. (2007), Janicak, et al. (2008), Avery, et al. (2008), and Lisanby, et al. (2009) present findings from pivotal registration trial for the Neuronetics NeuroStar system, while that from George, et al. (2010) presents findings from the independent NIH-funded OPT-TMS trial. The report from Janicak, et al. (2010) addresses questions of durability of response.

We participated…

in a multi-site clinical trial that addressed outcomes with real-world, care-seeking patients in a clinically-directed TMS treatment protocol
(Carpenter, et al., 2012; Janicak, et al., 2013).

Bibliography on the efficiency of Repetitive transcranial magnetic stimulation (rTMS) against Depression

• Gross M, Nakamura L, Pascual-Leone A, Fregni F.
"Has repetitive transcranial magnetic stimulation (rTMS) treatment for depression improved? A systematic review and meta-analysis comparing the recent vs. the earlier rTMS studies." Acta Psychiatr Scand. 2007 Sep; 116(3):165-73. abstract

• O'Reardon JP, Solvason HB, Janicak PG, Sampson S, Isenberg KE, Nahas Z, McDonald WM, Avery D, Fitzgerald PB, Loo C, Demitrack MA, George MS, Sackeim HA. "Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial." Biol Psychiatry. 2007 Dec 1; 62(11):1208-16. abstract

• Janicak PG, O'Reardon JP, Sampson SM, Husain MM, Lisanby SH, Rado JT, Heart KL, Demitrack MA. "Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary of safety experience from acute exposure, extended exposure, and during reintroduction treatment." J Clin Psychiatry. 2008 Feb; 69(2):222-32. abstract

• Avery DH, Isenberg KE, Sampson SM, Janicak PG, Lisanby SH, Maixner DF, Loo C, Thase ME, Demitrack MA, George MS. "Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial." J Clin Psychiatry. 2008 Mar; 69(3):441-51. abstract

• Lisanby SH, Husain MM, Rosenquist PB, Maixner D, Gutierrez R, Krystal A, Gilmer W, Marangell LB, Aaronson S, Daskalakis ZJ, Canterbury R, Richelson E, Sackeim HA, George MS. "Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial." Neuropsychopharmacology. 2009 Jan; 34(2):522-34. abstract

• Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, O'Reardon JP, Loo C, Husain MH, Krystal A, Gilmer W, Dowd SM, Demitrack MA, Schatzberg AF. "Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study." Brain Stimul. 2010 Oct; 3(4):187-99. abstract

• George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M, Anderson B, Nahas Z, Bulow P, Zarkowski P, Holtzheimer PE 3rd, Schwartz T, Sackeim HA. "Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. " Arch Gen Psychiatry. 2010 May;67(5):507-16. abstract

• Slotema CW, Blom JD, Hoek HW, Sommer IE. "Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. " J Clin Psychiatry. 2010 Jul;71(7):873-84. abstract

• Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, Dunner DL, Lanocha K, Solvason HB, Demitrack MA. "Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice." Depress Anxiety. 2012 Jul;29(7):587-96. abstract

• Janicak PG, Dunner DL, Aaronson ST, Carpenter LL, Boyadjis TA, Brock DG, Cook IA, Lanocha K, Solvason HB, Bonneh-Barkay D, Demitrack MA. "Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice." CNS Spectr. 2013 Dec;18(6):322-32. abstract

• Leuchter AF, Cook IA, Jin Y, Phillips B. "The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder." Front Hum Neurosci. 2013 Feb 26;7:37. abstract

• Cook IA, Espinoza R, Leuchter AF. "Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation)." Neurosurg Clin N Am. 2014 Jan;25(1):103-16. abstract


Ring the bells that still can ring. Forget your perfect offering. There is a crack, a crack in everything. That's how the light gets in. 

From: Leonard Cohen

Contacts & Location

Opening Hours

Monday to Friday: 9 AM – 5 PM
Saturday: 9 AM – 3 PM
Sunday: Closed

General Inquiries

Tel: (514) 481-7867
Toll Free: 1 866.331-3431
Fax: (514) 933-6318 

Find Us!

3400 Jean-Talon Ouest,
Suite 100 Montreal, QC
H3R 2E8

metro   bus  handicap

Google Map

Google Map

See Google Map

Contacts & Location

Opening Hours

Monday to Friday: 9 AM – 5 PM
Saturday: 9 AM – 3 PM
Sunday: Closed

General Inquiries

Tel: (514) 481-7867
Toll Free: 1 866.331-3431
Fax: (514) 933-6318 

Find Us!

3400 Jean-Talon Ouest,
Suite 100 Montreal, QC
H3R 2E8

metro   bus  handicap

Google Map

Questions ?
neuro therapy montreal

1000 characters left
Our telephone : (514) 481-7867